"Simplicity is the key requirement for any insulin pen," says Dr Tim Bailey, MD, AMCR Institute, US, "everyone benefits when the pen is simple and easy to use - patients, doctors and nurses educating the patients."
FlexTouch® has an easy-touch button which requires very little force to inject the insulin - at any dose. "As FlexTouch® requires a very small force to inject it means that almost any patient can use it" remarks Dr Bailey.
Launch timing of FlexTouch® in specific EU countries is pending local negotiations in each country.
FlexTouch® is a prefilled insulin pen containing 300 units of insulin. It doses in 1 unit increments, from 1 to 80 units. It is compatible with NovoTwist® needles.
NovoTwist® comes in 5 mm (32G Tip) and 8 mm (30G) versions. An audible and tactile 'click' confirms attachment of the needle.
About Novo Nordisk
Headquartered in Denmark, Novo Nordisk is a global healthcare company with 87 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.